Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial
- PMID: 33206062
- PMCID: PMC7746357
- DOI: 10.18632/aging.202188
Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial
Abstract
Introduction: Aging is characterized by the progressive loss of physiological capacity. At the cellular level, two key hallmarks of the aging process include telomere length (TL) shortening and cellular senescence. Repeated intermittent hyperoxic exposures, using certain hyperbaric oxygen therapy (HBOT) protocols, can induce regenerative effects which normally occur during hypoxia. The aim of the current study was to evaluate whether HBOT affects TL and senescent cell concentrations in a normal, non-pathological, aging adult population.
Methods: Thirty-five healthy independently living adults, aged 64 and older, were enrolled to receive 60 daily HBOT exposures. Whole blood samples were collected at baseline, at the 30th and 60th session, and 1-2 weeks following the last HBOT session. Peripheral blood mononuclear cells (PBMCs) telomeres length and senescence were assessed.
Results: Telomeres length of T helper, T cytotoxic, natural killer and B cells increased significantly by over 20% following HBOT. The most significant change was noticed in B cells which increased at the 30th session, 60th session and post HBOT by 25.68%±40.42 (p=0.007), 29.39%±23.39 (p=0.0001) and 37.63%±52.73 (p=0.007), respectively. There was a significant decrease in the number of senescent T helpers by -37.30%±33.04 post-HBOT (P<0.0001). T-cytotoxic senescent cell percentages decreased significantly by -10.96%±12.59 (p=0.0004) post-HBOT. In conclusion, the study indicates that HBOT may induce significant senolytic effects including significantly increasing telomere length and clearance of senescent cells in the aging populations.
Keywords: aging; hyperbaric oxygen; length; senescence; telomere.
Conflict of interest statement
Figures




Similar articles
-
The effect of hyperbaric oxygen therapy on the pathophysiology of skin aging: a prospective clinical trial.Aging (Albany NY). 2021 Nov 16;13(22):24500-24510. doi: 10.18632/aging.203701. Epub 2021 Nov 16. Aging (Albany NY). 2021. PMID: 34784294 Free PMC article. Clinical Trial.
-
Hyperbaric oxygen therapy induces transcriptome changes in elderly: a prospective trial.Aging (Albany NY). 2021 Nov 24;13(22):24511-24523. doi: 10.18632/aging.203709. Epub 2021 Nov 24. Aging (Albany NY). 2021. PMID: 34818212 Free PMC article.
-
Rejuvenation Through Oxygen, More or Less.Rejuvenation Res. 2021 Apr;24(2):158-163. doi: 10.1089/rej.2021.0014. Rejuvenation Res. 2021. PMID: 33784834
-
Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics.Redox Biol. 2022 Jul;53:102352. doi: 10.1016/j.redox.2022.102352. Epub 2022 May 27. Redox Biol. 2022. PMID: 35649312 Free PMC article. Review.
-
Telomeres and Cell Senescence - Size Matters Not.EBioMedicine. 2017 Jul;21:14-20. doi: 10.1016/j.ebiom.2017.03.027. Epub 2017 Mar 21. EBioMedicine. 2017. PMID: 28347656 Free PMC article. Review.
Cited by
-
T-Cell Senescence in Human Metabolic Diseases.Diabetes Metab J. 2024 Sep;48(5):864-881. doi: 10.4093/dmj.2024.0140. Epub 2024 Aug 28. Diabetes Metab J. 2024. PMID: 39192822 Free PMC article. Review.
-
Plant telomere biology: The green solution to the end-replication problem.Plant Cell. 2022 Jul 4;34(7):2492-2504. doi: 10.1093/plcell/koac122. Plant Cell. 2022. PMID: 35511166 Free PMC article.
-
Cancer Evo-Dev: A Theory of Inflammation-Induced Oncogenesis.Front Immunol. 2021 Nov 22;12:768098. doi: 10.3389/fimmu.2021.768098. eCollection 2021. Front Immunol. 2021. PMID: 34880864 Free PMC article.
-
Integrative Role of Hyperbaric Oxygen Therapy on Healthspan, Age-Related Vascular Cognitive Impairment, and Dementia.Front Aging. 2021 Sep 23;2:678543. doi: 10.3389/fragi.2021.678543. eCollection 2021. Front Aging. 2021. PMID: 35821996 Free PMC article. Review.
-
The effect of hyperbaric oxygen therapy on the pathophysiology of skin aging: a prospective clinical trial.Aging (Albany NY). 2021 Nov 16;13(22):24500-24510. doi: 10.18632/aging.203701. Epub 2021 Nov 16. Aging (Albany NY). 2021. PMID: 34784294 Free PMC article. Clinical Trial.
References
-
- Tsoukalas D, Fragkiadaki P, Docea AO, Alegakis AK, Sarandi E, Vakonaki E, Salataj E, Kouvidi E, Nikitovic D, Kovatsi L, Spandidos DA, Tsatsakis A, Calina D. Association of nutraceutical supplements with longer telomere length. Int J Mol Med. 2019; 44:218–26. 10.3892/ijmm.2019.4191 - DOI - PMC - PubMed
-
- Starkweather AR, Alhaeeri AA, Montpetit A, Brumelle J, Filler K, Montpetit M, Mohanraj L, Lyon DE, Jackson-Cook CK. An integrative review of factors associated with telomere length and implications for biobehavioral research. Nurs Res. 2014; 63:36–50. 10.1097/NNR.0000000000000009 - DOI - PMC - PubMed
-
- Puhlmann LM, Valk SL, Engert V, Bernhardt BC, Lin J, Epel ES, Vrticka P, Singer T. Association of short-term change in leukocyte telomere length with cortical thickness and outcomes of mental training among healthy adults: a randomized clinical trial. JAMA Netw Open. 2019; 2:e199687. 10.1001/jamanetworkopen.2019.9687 - DOI - PMC - PubMed
-
- Åström MJ, von Bonsdorff MB, Perälä MM, Salonen MK, Rantanen T, Kajantie E, Simonen M, Pohjolainen P, Haapanen MJ, Guzzardi MA, Iozzo P, Kautiainen H, Eriksson JG. Telomere length and physical performance among older people-the helsinki birth cohort study. Mech Ageing Dev. 2019; 183:111145. 10.1016/j.mad.2019.111145 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical